🏛️ Verified NIH Record • Updated 2026-07-20
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD (NCT05936970)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Aqtual, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The primary goal of this study is to assess a cfDNA-based blood test using genetic, transcriptomic and/or epigenetic information to help doctors predict the best treatment options for rheumatoid arthritis (RA) patients with inadequate response or intolerance to previous therapies.
Who can join: Review the eligibility criteria below.
Location: Arizona Arthritis & Rheumatology Research — Phoenix, Arizona
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (42 Sites)
Showing the first 25 of 42 sites.
- Arizona Arthritis & Rheumatology Research — Phoenix, Arizona
- Medvin Clinical Research - Apple Valley — Apple Valley, California
- Medvin Clinical Research - Covina — Covina, California
- Medvin Clinical Research - Riverside — Riverside, California
- Medvin Clinical Research - Tujunga — Tujunga, California
- Medvin Clinical Research - Whittier — Whittier, California
- AARDS Research, Inc — Aventura, Florida
- Highlands Advanced Rheumatology and Arthritis Center (HARAC) — Avon Park, Florida
- Bay Area Rheumatology — Clearwater, Florida
- Believe Clinical Trials — Coral Springs, Florida
- GNP Research — Hollywood, Florida
- Life Clinical Trials — Margate, Florida
- Vitalia Medical Research — Palm Beach Gardens, Florida
- Shine a Light Research — Sun City Center, Florida
- West Broward Rheumatology Associates — Tamarac, Florida
- St. Luke's Clinic — Boise, Idaho
- Arnold Arthritis & Rheumatology — Skokie, Illinois
- Illinois Bone and Joint Institute — Willowbrook, Illinois
- Lake Cumberland Rheumatology — New Albany, Indiana
- Clinical Research Institute of Michigan — Saint Clair Shores, Michigan
- St. Paul Rheumatology — Eagan, Minnesota
- AARA/Kansas City Physician Partners — Kansas City, Missouri
- New England Rheumatology & Osteoporosis — Henniker, New Hampshire
- Arthritis Rheumatism and Bone Disease Associates — Voorhees Township, New Jersey
- Sahni Rheumatology & Therapy — West Long Branch, New Jersey
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Rheumatoid Arthritis
- A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis. — Santa Monica, California
- Employment and Arthritis: Making it Work — Richmond, British Columbia
- Brigham and Women's Rheumatoid Arthritis Sequential Study — Boston, Massachusetts
- A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) — Flagstaff, Arizona
- A Study of SPY072 in Rheumatic Disease — Avondale, Arizona
Explore by condition: All Rheumatoid Arthritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.